Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Le Loët

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|March 21, 2006
[Diagnosis of early arthritis]Xavier Le Loët, Nathalie Klemmer
Joint Bone Spine|May 25, 2002
The sternocostoclavicular joint: normal and abnormal featuresXavier Le Loët, Olivier Vittecoq
BMC Musculoskeletal Disorders|June 17, 2005
Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre studyXavier Le Loët, Karel Pavelka, Ute Richarz
Joint Bone Spine|July 26, 2005
Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally"Thierry Lequerré, Olivier Vittecoq, Xavier Le Loët
Joint Bone Spine|November 1, 2005
Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of viewXavier Le Loët, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|March 21, 2007
What is the role for interleukin-1 receptor antagonist in rheumatic disease?Thierry Lequerré, Olivier Vittecoq, Xavier le Loët
La Revue Du Praticien|May 11, 2002
[Synovial diseases of the hip]Xavier Le Loët, Sophie Pouplin, Olivier Vittecoq
Joint Bone Spine|July 6, 2005
The preclinical phase of rheumatoid arthritis and lupusOlivier Vittecoq, Vincent Goeb, Xavier Le Loët, et al.
Clinical Rheumatology|March 27, 2004
Cerivastatin-induced polymyalgia rheumatica-like illnessVincent Goëb, Nathalie Guillemant, Olivier Vittecoq, et al.
La Revue Du Praticien|December 12, 2012
[Goals of therapy in rheumatoid arthritis]Xavier Le Loët, Vincent Goëb, Olivier Vittecoq, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|March 21, 2006
[Diagnosis of early arthritis]Xavier Le Loët, Nathalie Klemmer
Joint Bone Spine|May 25, 2002
The sternocostoclavicular joint: normal and abnormal featuresXavier Le Loët, Olivier Vittecoq
BMC Musculoskeletal Disorders|June 17, 2005
Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre studyXavier Le Loët, Karel Pavelka, Ute Richarz
Joint Bone Spine|July 26, 2005
Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally"Thierry Lequerré, Olivier Vittecoq, Xavier Le Loët
Joint Bone Spine|November 1, 2005
Rheumatoid arthritis in 2005: which patients should receive TNFalpha antagonists and when? A point of viewXavier Le Loët, Thierry Lequerré, Olivier Vittecoq
Joint Bone Spine|March 21, 2007
What is the role for interleukin-1 receptor antagonist in rheumatic disease?Thierry Lequerré, Olivier Vittecoq, Xavier le Loët
La Revue Du Praticien|May 11, 2002
[Synovial diseases of the hip]Xavier Le Loët, Sophie Pouplin, Olivier Vittecoq
Joint Bone Spine|July 6, 2005
The preclinical phase of rheumatoid arthritis and lupusOlivier Vittecoq, Vincent Goeb, Xavier Le Loët, et al.
Clinical Rheumatology|March 27, 2004
Cerivastatin-induced polymyalgia rheumatica-like illnessVincent Goëb, Nathalie Guillemant, Olivier Vittecoq, et al.
La Revue Du Praticien|December 12, 2012
[Goals of therapy in rheumatoid arthritis]Xavier Le Loët, Vincent Goëb, Olivier Vittecoq, et al.
Pageof 10